HOME >> Business >> Regenerative Medicine Business


Regenerative Medicine Business

Unlike conventional drug treatment or organ transplants, regenerative medicine draws out the regenerative capabilities of our own bodies’ tissues, focusing on the utilization of living cells to recover the lost functions of tissue or organs in a person’s body. The main business goal at J-TEC is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for the purpose of medical treatment.

J-TEC’s tissue-engineered medical products are meant to be used in “autologous transplant” cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Three Product Lines

  • Autologous Cultured Epidermis
  • Autologous Cultured Cartilage

Business Model for an Autologous Cultured Product

Tissue-engineered medical products are subject to The Pharmaceutical and Medical Device Act which requires the approval of the Welfare, Health and Labor Ministry in order to sell these products. Business Model for an Autologous Cultured Product

  • The doctor (medical facility) takes a sample of healthy tissue which has not been injured from the patient.
  • J-TEC cultures cells from the treated tissue, carries out a pre-shipment inspection, packages the product and sends it back to the medical institution.
  • A tissue transplant operation is carried out by a doctor (medical facility) for the same patient.